Stryker’s (NYSE:SYK) Australian arm provided national health regulators with updated recommendations for monitoring patients who received the company’s now-recalled ABG II Modular hip systems.
Metal-on-Metal
More hip recalls for Johnson & Johnson?
International reports today suggest that healthcare giant Johnson & Johnson (NYSE:JNJ) recalled its Adept hip replacement system, another in its line of troubled metal-on-metal hip implants.
Lawsuit: Stryker should cover Fla. patients’ medical monitoring over recalled Rejuvenate hip implant
J&J dodged years of warnings before recalling metal hips, lawsuit claims
New documents unveiled during trial proceedings don’t bode well for Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics.
Emails and internal memos suggest that the metal-on-metal hip maker for years hid concerns about the failure rates of its ASR implants, which are now the subject of a high-profile recall and thousands of patient injury lawsuits.
1 in 3 metal hips may fail in under 5 years, J&J analysis finds
An internal analysis conducted by Johnson & Johnson (NYSE:JNJ) concluded that 37% of subsidiary DePuy Orthopaedics’ metal-on-metal ASR hip implants would fail within 5 years, according to documents uncovered during a patient injury lawsuit.
Zimmer slips 2nd Durom lawsuit
DePuy aims to dismiss patient lawsuit against recalled hip implant
Stryker can’t dodge Trident hip lawsuit
Texas DePuy hip implant lawsuit docket tops 750 complaints
A Lone Star State multi-district lawsuit against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics has grown to include 757 complaints as federal courts around the country transfer cases to the Northern District of Texas.
Zimmer tallies remaining legal costs for temporarily recalled Durom MoM hips at nearly $230M
Corrected November 9, 2012, at 3:45 p.m.
Orthopedic devices maker Zimmer Holdings (NYSE:ZMH) expects to pay another $229.7 million to handle legal complaints spurred by the temporary 2008 recall of its Durom metal-on-metal acetabular hip components, according to the company’s latest earnings release.
Zimmer pulls metal-on-metal Durom acetabular hip implants from Australian market
In another blow to the metal-on-metal hip implant market, orthopedic giant Zimmer Holdings (NYSE:ZMH) canceled its Durom Acetabular Component from the Australian Register of Therapeutic Goods, the regulatory agency announced this week.